Suppr超能文献

微小 RNA、巴雷特食管的发育和食管腺癌的进展。

MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.

出版信息

World J Gastroenterol. 2010 Feb 7;16(5):531-7. doi: 10.3748/wjg.v16.i5.531.

Abstract

Barrett's esophagus is a premalignant condition caused by gastroesophageal reflux. Once developed, it can progress through varying grades of dysplasia to esophageal adenocarcinoma. Whilst it is well accepted that Barrett's esophagus is caused by gastroesophageal reflux, the molecular mechanisms of its pathogenesis and progression to cancer remain unclear. MicroRNAs (miRNAs) are short segments of RNA that have been shown to control the expression of many human genes. They have been implicated in most cellular processes, and the role of miRNAs in disease development is becoming increasingly evident. Understanding altered miRNA expression is likely to help unravel the molecular mechanisms that underpin the development of Barrett's esophagus and its progression to cancer.

摘要

巴雷特食管是一种由胃食管反流引起的癌前病变。一旦发生,它可以通过不同程度的异型增生进展为食管腺癌。虽然人们普遍认为巴雷特食管是由胃食管反流引起的,但它的发病机制和进展为癌症的分子机制仍不清楚。 microRNAs(miRNAs)是短的 RNA 片段,已经被证明可以控制许多人类基因的表达。它们参与了大多数细胞过程,miRNAs 在疾病发展中的作用也越来越明显。了解 miRNA 表达的改变可能有助于揭示支持巴雷特食管发展及其进展为癌症的分子机制。

相似文献

1
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
World J Gastroenterol. 2010 Feb 7;16(5):531-7. doi: 10.3748/wjg.v16.i5.531.
2
Risk factors for neoplastic progression in Barrett's esophagus.
World J Gastroenterol. 2011 Aug 28;17(32):3672-83. doi: 10.3748/wjg.v17.i32.3672.
3
[Carcinogenesis of Barrett's esophagus].
Nihon Rinsho. 2005 Aug;63(8):1357-61.
4
Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5. doi: 10.1158/1055-9965.EPI-04-0509.
5
MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Cancer Prev Res (Phila). 2013 Mar;6(3):196-205. doi: 10.1158/1940-6207.CAPR-12-0276.
6
Gastroesophageal reflux disease: From heartburn to cancer.
World J Gastroenterol. 2010 Aug 14;16(30):3743-4. doi: 10.3748/wjg.v16.i30.3743.
7
Short-segment Barrett's esophagus: A prevalent complication of gastroesophageal reflux disease with malignant potential.
J Gastrointest Surg. 1997 Mar-Apr;1(2):113-22. doi: 10.1016/s1091-255x(97)80098-4.
8
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Clin Cancer Res. 2009 Sep 15;15(18):5744-52. doi: 10.1158/1078-0432.CCR-09-0385. Epub 2009 Sep 8.
10
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
World J Gastroenterol. 2015 May 7;21(17):5210-9. doi: 10.3748/wjg.v21.i17.5210.

引用本文的文献

1
miRNA-221 and miRNA-483-3p Dysregulation in Esophageal Adenocarcinoma.
Cancers (Basel). 2024 Jan 30;16(3):591. doi: 10.3390/cancers16030591.
2
Five-Class Classification of Cervical Pap Smear Images: A Study of CNN-Error-Correcting SVM Models.
Healthc Inform Res. 2021 Oct;27(4):298-306. doi: 10.4258/hir.2021.27.4.298. Epub 2021 Oct 31.
3
A microRNA Signature Identifies Patients at Risk of Barrett Esophagus Progression to Dysplasia and Cancer.
Dig Dis Sci. 2022 Feb;67(2):516-523. doi: 10.1007/s10620-021-06863-0. Epub 2021 Mar 13.
4
Identification of potential key genes in esophageal adenocarcinoma using bioinformatics.
Exp Ther Med. 2019 Nov;18(5):3291-3298. doi: 10.3892/etm.2019.7973. Epub 2019 Sep 5.
5
Framework for microRNA variant annotation and prioritization using human population and disease datasets.
Hum Mutat. 2019 Jan;40(1):73-89. doi: 10.1002/humu.23668. Epub 2018 Nov 8.
7
MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
World J Gastroenterol. 2017 Aug 14;23(30):5508-5518. doi: 10.3748/wjg.v23.i30.5508.
8
Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.
J Cell Mol Med. 2018 Jan;22(1):123-130. doi: 10.1111/jcmm.13300. Epub 2017 Aug 10.
9
From blood to breath: New horizons for esophageal cancer biomarkers.
World J Gastroenterol. 2016 Dec 14;22(46):10077-10083. doi: 10.3748/wjg.v22.i46.10077.
10
miR-203 is a predictive biomarker for colorectal cancer and its expression is associated with BIRC5.
Tumour Biol. 2016 Dec;37:15989–15995. doi: 10.1007/s13277-016-5438-7. Epub 2016 Oct 6.

本文引用的文献

2
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival.
Clin Cancer Res. 2009 Oct 1;15(19):6192-200. doi: 10.1158/1078-0432.CCR-09-1467. Epub 2009 Sep 29.
3
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma.
Clin Cancer Res. 2009 Sep 15;15(18):5744-52. doi: 10.1158/1078-0432.CCR-09-0385. Epub 2009 Sep 8.
5
Modulation of microRNA processing by p53.
Nature. 2009 Jul 23;460(7254):529-33. doi: 10.1038/nature08199.
6
EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Int J Cancer. 2010 Jan 1;126(1):114-24. doi: 10.1002/ijc.24695.
7
Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.
Leuk Res. 2009 Nov;33(11):1530-8. doi: 10.1016/j.leukres.2009.04.019. Epub 2009 May 21.
8
Decreased expression of microRNA-143 and -145 in human gastric cancers.
Oncology. 2009;77(1):12-21. doi: 10.1159/000218166. Epub 2009 May 12.
9
The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 2009 May;136(5):1689-700. doi: 10.1053/j.gastro.2009.02.002.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验